Source Intrinsiq News Today : Breaking News, Live Updates & Top Stories | Vimarsana

STOCKHOLM, Oct. 26, 2022 /PRNewswire/ Oncopeptides AB (publ) (NASDAQ Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological

United statesUnited kingdomCastillay leópEuropean commissionDrug administrationGlobal head of corporate communicationsSalamanca university hospital haematology departmentEuropean unionEuropean medicines agencyOverall response rateVictoria mateosUniversity hospital haematology departmentLead investigatorCorporate communicationsPeptide drug candidateMarketing authorization